Remdesivir can Now Be Bought Directly From the Company
Supply of our investigational COVID-19 treatment is now meeting demand in the U.S. Today, Gilead has assumed responsibility for U.S. distribution of the drug. Read more: https://t.co/MtZVLkL3SH
— Gilead Sciences (@GileadSciences) October 1, 2020
Health Editor’s Note: Gilead is able to keep production of remdesivir (veklury) up and is meeting demand for this antiviral in the U.S. Remdesivir is currently authorized for Temporary use under an Emergency Use Authorization (EUA) for treatment of COVID-19 patients in the hospital, moderate to severe disease, regardless of the need for supplemental oxygen.
At this point I am wondering what more this drug needs to do to be considered acceptable treatment for COVID-19? The only potential difficulty I see in the use of remdesivir is that it has to be administered by IV (one dose and then a loading dose daily for up to 10 days) which limits who can administer it. ……Carol
Carol graduated from Riverside White Cross School of Nursing in Columbus, Ohio and received her diploma as a registered nurse. She attended Bowling Green State University where she received a Bachelor of Arts Degree in History and Literature. She attended the University of Toledo, College of Nursing, and received a Master’s of Nursing Science Degree as an Educator.
She has traveled extensively, is a photographer, and writes on medical issues. Carol has three children RJ, Katherine, and Stephen – one daughter-in-law; Katie – two granddaughters; Isabella Marianna and Zoe Olivia – and one grandson, Alexander Paul. She also shares her life with her husband Gordon Duff, many cats, and two rescues.